Your browser doesn't support javascript.
Aerosol Generation and Mitigation During Methacholine Bronchoprovocation Testing: Infection Control Implications in the Era of COVID-19.
Subat, Yosuf W; Hainy, Matthew E; Torgerud, Keith D; Sajgalik, Pavol; Guntupalli, Siva Kamal; Johnson, Bruce D; Chul-Ho, Kim; Lim, Kaiser G; Helgeson, Scott A; Scanlon, Paul D; Niven, Alexander S.
  • Subat YW; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Hainy ME; Division of Engineering, Mayo Clinic, Rochester, Minnesota.
  • Torgerud KD; Respiratory Care and Cardiopulmonary Diagnostics, Mayo Clinic, La Crosse, Wisconsin.
  • Sajgalik P; Human Integrative and Environmental Physiology Laboratory, Department of Cardiology, Mayo Clinic, Rochester, Minnesota.
  • Guntupalli SK; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Johnson BD; Human Integrative and Environmental Physiology Laboratory, Department of Cardiology, Mayo Clinic, Rochester, Minnesota.
  • Chul-Ho K; Human Integrative and Environmental Physiology Laboratory, Department of Cardiology, Mayo Clinic, Rochester, Minnesota.
  • Lim KG; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Helgeson SA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Florida.
  • Scanlon PD; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
  • Niven AS; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota. niven.alexander@mayo.edu.
Respir Care ; 66(12): 1858-1865, 2021 12.
Article in English | MEDLINE | ID: covidwho-1524338
ABSTRACT

BACKGROUND:

Methacholine bronchoprovocation or challenge testing (MCT) is commonly performed to assess airway hyper-responsiveness in the setting of suspected asthma. Nebulization is an aerosol-generating procedure, but little is known about the risks of MCT in the context of the ongoing coronavirus disease 2019 (COVID-19) pandemic. We aimed to quantify and characterize aerosol generation during MCT by using different delivery methods and to assess the impact of adding a viral filter.

METHODS:

Seven healthy subjects performed simulated MCT in a near particle-free laboratory space with 4 different nebulizers and with a dosimeter. Two devices continuously sampled the ambient air during the procedure, which detected ultrafine particles, from 0.02-1 µm, and particles of sizes 0.3, 0.5, 1.0, 2.0, 5.0, and 10 µm, respectively. Particle generation was compared among all the devices, with and without viral filter placement.

RESULTS:

Ultrafine-particle generation during simulated MCT was significant across all the devices. Ultrafine-particle (0.02-1 µm) concentrations decreased 77%-91% with the addition of a viral filter and varied significantly between unfiltered (P < .001) and filtered devices (P < .001). Ultrafine-particle generation was lowest when using the dosimeter with filtered Hudson nebulizer (1,258 ± 1,644 particle/mL). Ultrafine-particle concentrations with the filtered nebulizer devices using a compressor were higher than particle concentrations detected when using the dosimeter Monaghan (3,472 ± 1,794 particles/mL), PARI (4,403 ± 2,948), Hudson (6,320 ± 1,787) and AirLife (9,523 ± 5,098).

CONCLUSIONS:

The high particle concentrations generated during MCT pose significant infection control concerns during the COVID-19 pandemic. Particle generation during MCT was significantly reduced by using breath-actuated delivery and a viral filter, which offers an effective mitigation strategy.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Respir Care Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Respir Care Year: 2021 Document Type: Article